|
1
|
Roulin L, Jais J, Poullot E, Robe C, Scherman E, Lemonnier F, Le Bras F, Maarek A, Belhadj K, Dupuis J, Hammoud M, El Gnaoui T, Mule S, Itti E, Delfau-Larue M, Gaulard P, Haioun C, Copie-Bergman C. CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON-BURKITT) B-CELL LYMPHOMA IN A REAL LIFE COHORT. Hematol Oncol 2019. [DOI: 10.1002/hon.13_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- L. Roulin
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - J. Jais
- Biostatistics; Necker Hospital, APHP; Paris France
| | - E. Poullot
- Pathology Department; Henri Mondor Hospital, APHP; Créteil France
| | - C. Robe
- Pathology Department; Henri Mondor Hospital, APHP; Créteil France
| | | | - F. Lemonnier
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - F. Le Bras
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - A. Maarek
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - K. Belhadj
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - J. Dupuis
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - M. Hammoud
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - T. El Gnaoui
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - S. Mule
- Radiology Department; Henri Mondor Hospital, APHP; Créteil France
| | - E. Itti
- Nuclear Medicine Department; Henri Mondor Hospital, APHP; Créteil France
| | - M. Delfau-Larue
- Immunobiology and Haematology Department; Henri Mondor Hospital, APHP; Créteil France
| | - P. Gaulard
- Pathology Department; Henri Mondor Hospital, APHP; Créteil France
| | - C. Haioun
- Lymphoid malignancies Unit; Henri Mondor Hospital, APHP; Créteil France
| | - C. Copie-Bergman
- Pathology Department; Henri Mondor Hospital, APHP; Créteil France
| |
Collapse
|
|
2
|
Le Gouill S, Beldi-Ferchiou A, Cacheux V, Salles G, Canioni D, Bodet-Milin C, Alcantara M, Delwail V, Gastinne T, Thieblemont C, Maisonneuve H, Lamy de la Chapelle T, Oberic L, Bouabdallah K, Ribrag V, Delfau-Larue M, Macintyre E, Hermine O. OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA-101 TRIAL, A LYSA GROUP STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.14_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - V. Cacheux
- Hematologie; CHU Clermont-Ferrand; Clermont-Ferrand France
| | | | | | | | | | - V. Delwail
- Hematology Biology; CHU Poitiers; Poitiers France
| | | | | | - H. Maisonneuve
- Hematology-Oncology; CH Roche-Sur-Yon; Roche-Sur-Yon France
| | | | - l. Oberic
- Hematology; Oncopole de Toulouse; Toulouse France
| | | | - V. Ribrag
- Hematology; Institut Gustave Roussy; Villejuif France
| | | | - E. Macintyre
- Hématologie Biologique; Hôpital Necker; Paris France
| | - O. Hermine
- Hematologie; Hôpital Necker; Paris France
| |
Collapse
|
|
3
|
Ribrag V, Feugier P, Doorduijn J, Delfau-Larue M, Hermine O, Kluin-Nelemans H, Dasilva M, Lopez-Hernandez A, Walewski J, Szymczyk M, Pott C, Homburg C, Van der Velden V, Gameiro P, Garcia-Sanz R, Ladetto M, van Krieken H, Cabeçadas J, Rymkiewicz G, Klapper W, Hoster E, Le Gouill S, Dreyling M. MCL-R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK
ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R-CHOP / R-HAD) AND a RITUXIMAB-LENALIDOMIDE MAINTENANCE. Hematol Oncol 2017. [DOI: 10.1002/hon.2440_3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- V. Ribrag
- Hematology; Gustave Roussy Cancer Campus; Villejuif France
| | - P. Feugier
- Hematology; Hôpitaux De Brabois; Vandoeuvre-Les-Nancy France
| | - J. Doorduijn
- Hematology; Department of Hematology, Erasmus MC; Rotterdam Netherlands
| | - M. Delfau-Larue
- Hématologie et Immunologie Biologiques; GH Henri Mondor; Creteil France
| | - O. Hermine
- Hematology; Groupe Hospitalier : Hôpital Universitaire Necker-Enfants Malades; Paris France
| | - H. Kluin-Nelemans
- Department of Hematology; University Medical Center Groningen, University of Groningen; Groningen Netherlands
| | - M. Dasilva
- Serviço De Hematologia; Instituto Português De Oncologia De Lisboa; Lisbon Portugal
| | | | - J. Walewski
- Lymphoid Malignancy; Maria Sklodowska-Curie Institute - Oncology Center; Warszawa Poland
| | - M. Szymczyk
- Lymphoid Malignancy; Maria Sklodowska-Curie Institute - Oncology Center; Warszawa Poland
| | - C. Pott
- Klinisch-Experimentelle Hämatologie; Universitätsklinikum Schleswig-Holstein; Kiel Germany
| | - C. Homburg
- Laboratoriumhoofd Immunocytologie; Sanquin Diagnostiek; Amsterdam Netherlands
| | - V. Van der Velden
- Hematology; Department of Hematology, Erasmus MC; Rotterdam Netherlands
| | - P. Gameiro
- Biologia Molecular Laboratório De Hemato-Oncologia; Instituto Português De Oncologia De Lisboa; Lisbon Portugal
| | | | - M. Ladetto
- Hematology; Azienda Ospedaliera Nazionale SS.Antonio e Biagio e C. Arrigo; Alessandria Italy
| | - H. van Krieken
- Pathology; Radboud University Medical Center; Nijmegen Netherlands
| | - J. Cabeçadas
- Serviço De Anatomia Patológica; Instituto Português De Oncologia De Lisboa; Lisbon Portugal
| | - G. Rymkiewicz
- Lymphoid Malignancy; Maria Sklodowska-Curie Institute - Oncology Center; Warszawa Poland
| | - W. Klapper
- Institut Für Pathologie, Sektion Hämatopathologie und Lymphknotenregister; Universitätsklinikum Schleswig-Holstein, Campus Kiel; Kiel Germany
| | - E. Hoster
- Department of Medicine III; University Hospital of Munich; Munich Germany
| | - S. Le Gouill
- Service d'Hématologie; CHU de Nantes; Nantes France
| | - M. Dreyling
- Department of Medicine III; University Hospital of Munich; Munich Germany
| |
Collapse
|
|
4
|
Lemonnier F, Safar V, Cottereau A, Fataccioli V, Chaillol I, Pelletier R, Letourneau A, Dupuy A, Bossard C, Martin A, Robe C, Pelletier L, Pujals A, Bachy E, Delmer A, Moles Moreau M, Tilly H, Parrens M, Delfau-Larue M, Missiaglia E, Meignan M, de Leval L, Haioun C, Gaulard P. INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH TET2, IDH2, DNMT3A, AND RHOA MUTATIONS IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: A LYSA STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- F. Lemonnier
- INSERMU955, Unité Hémopathies Lymphoïdes; Université Paris Est, Hôpitaux universitaire Henri Mondor; Créteil France
| | - V. Safar
- Hématologie clinique; Centre Hopsitalier Lyon Sud; Pierre Bénite France
| | - A. Cottereau
- Médecine nucléaire; Hôpital Tenon, APHP; Paris France
| | - V. Fataccioli
- INSERMU955; Institut Mondor de Recherche Biomédicale; Créteil France
| | - I. Chaillol
- Lysarc; Centre Hospitalier Lyon Sud; Pierre Bénite France
| | - R. Pelletier
- INSERMU955; Institut Mondor de Recherche Biomédicale; Créteil France
| | - A. Letourneau
- Pathologie; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - A. Dupuy
- INSERMU955; Institut Mondor de Recherche Biomédicale; Créteil France
| | - C. Bossard
- Anatomie et cytologie pathologique; Hotel Dieu, CHU Nantes; Nantes France
| | - A. Martin
- anatomie pathologique, Hôpital Avicenne; Bobigny France
| | - C. Robe
- INSERMU955; Institut Mondor de Recherche Biomédicale; Créteil France
| | - L. Pelletier
- INSERMU955; Institut Mondor de Recherche Biomédicale; Créteil France
| | - A. Pujals
- INSERMU955, Département de Pathologie; Université Paris Est, Hôpitaux Universitaires Henri Mondor; Créteil France
| | - E. Bachy
- Lysarc; Centre Hospitalier Lyon Sud; Pierre Bénite France
| | - A. Delmer
- hématologie clinique; centre hospitalier universitaire; Reims France
| | - M. Moles Moreau
- hématologie clinique; centre hospitalier universitaire; Angers France
| | - H. Tilly
- Hématologie clinique; CLCC Henri Becquerel; Rouen France
| | - M. Parrens
- Pathologie; Hôpital Haut-Lévêque; Pessac France
| | - M. Delfau-Larue
- Immunologie biologique; Hôpitaux universitaires Henri Mondor; Créteil France
| | - E. Missiaglia
- Pathologie; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - M. Meignan
- LYSA image; Hôpitaux Universitaires Henri Mondor; Créteil France
| | - L. de Leval
- Pathologie; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - C. Haioun
- INSERMU955, Unité Hémopathies Lymphoïdes; Université Paris Est, Hôpitaux universitaire Henri Mondor; Créteil France
| | - P. Gaulard
- INSERMU955, Département de Pathologie; Université Paris Est, Hôpitaux Universitaires Henri Mondor; Créteil France
| |
Collapse
|
|
5
|
Joly B, Plonquet A, Grare M, Delfau-Larue M, Delarue R, Delmer A, Casasnovas O, Gisselbrecht C, Gaulard P, Haioun C. Rituximab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma: Results of the phase II RAIL trial—A prospective study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8049] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|